at Nasdaq.com (Jan 16, 2015)
Goldman Sachs stays bullish on CVS Caremark (CVS) as it reiterates a Buy rating and tacks on dollar to lift its price target on shares to $44. Analysts with the firm call CVS a "perfect fit" for large-cap investors on the strength of a "predictable operating algorithm" and solid capital allocation. Shares +0.2% premarket.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 15, 2015)
at Zacks.com (Jan 14, 2015)
at Benzinga.com (Jan 14, 2015)
at CNBC.com (Jan 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs